Medication Adherence in Thoracic Transplant Candidates: A Multi-Center Study Uncovers Key Predictors and Implications for Patient Outcomes

The critical role of medication adherence in the success of thoracic organ transplantation has long been recognized. However, identifying patients at risk of non-adherence prior to receiving a lung, heart, or heart-lung transplant remains a significant challenge for clinicians. A recent multi-center study, published in Frontiers in Psychology, has shed new light on this issue, revealing that a substantial portion of thoracic organ candidates exhibit medication non-adherence and pinpointing specific patient-related factors that may predict these behaviors. The research utilized the Simplified Medication Adherence Questionnaire (SMAQ) to assess adherence and explored correlations with demographic, psychosocial, and emotional health characteristics.

Pre-Transplant Adherence: A Crucial, Yet Elusive, Factor

The success of modern thoracic transplantation, marked by significant improvements in post-transplant survival rates—a median of 12.5 years for heart recipients and 6.2 years for lung recipients, according to recent data—is heavily reliant on patients adhering to complex and lifelong medication regimens. These regimens typically include potent immunosuppressants to prevent organ rejection, as well as antimicrobials and other supportive therapies. Non-adherence to these vital medications has been consistently linked to poorer clinical outcomes, including increased rates of organ rejection, graft failure, hospitalizations, and even mortality. Despite this well-established link, effectively identifying and intervening with at-risk candidates before transplantation presents a considerable hurdle for transplant centers.

While many centers consider medication non-adherence a relative contraindication for transplantation, the proactive identification of vulnerable individuals is paramount. Previous research has explored various factors, including demographic information, socioeconomic status, and emotional states, as potential predictors of non-adherence in solid organ recipients. Psychosocial assessments conducted during the pre-transplant evaluation have also shown promise in predicting post-transplant adherence. Given the established connection between underlying psychiatric conditions, such as anxiety and depression, and medication non-adherence, routine pre-transplant screening for these factors is becoming increasingly common.

However, the landscape of pre-transplant adherence, particularly among thoracic transplant candidates, remains less comprehensively understood than its post-transplant counterpart. Studies, such as the Swiss Transplant Cohort Study, have indicated that pre-transplant non-adherence is a strong predictor of similar behavior after transplantation across various organ types. Another investigation involving heart, lung, and liver transplant candidates identified associations between education levels, social support, and personality traits like conscientiousness with pre-transplant medication non-adherence.

The Simplified Medication Adherence Questionnaire (SMAQ) and its Application

To address the need for concise and practical tools to identify at-risk patients, the Simplified Medication Adherence Questionnaire (SMAQ) was employed in this study. The SMAQ is a validated, six-item instrument designed to assess general medication adherence across diverse medical conditions. Its brevity and reliability make it particularly suitable for mailed surveys, capturing both intentional and unintentional non-adherence. The study’s primary aim was to evaluate medication adherence rates among thoracic transplant candidates using the SMAQ and to identify associated patient-specific factors.

Study Design and Methodology

The research involved 298 adult lung, heart, and heart-lung transplant candidates from six thoracic transplant centers across the United States. Participants were mailed a survey containing demographic information and the SMAQ. The study also incorporated other validated psychometric instruments to assess various psychological dimensions: the Positive and Negative Affect Schedule (PANAS) for emotional states, the Generalized Anxiety Disorder Scale-2 (GAD-2) and Patient Health Questionnaire-2 (PHQ-2) for screening anxiety and depression symptoms, and the Mishel Uncertainty in Illness Scale (MUIS) for measuring illness uncertainty. Data on patient characteristics were abstracted from electronic medical records, and follow-up data on transplant outcomes were collected through May 1, 2020. Univariate logistic regression analysis was used to examine associations between pre-transplant medication adherence and various patient factors.

Key Findings: A High Prevalence of Non-Adherence and Predictors

The study revealed a striking finding: 60.7% of the 298 participants were identified as medication non-adherent (MNA) using the SMAQ. This prevalence did not significantly differ between heart and lung transplant candidates. The research identified several key patient-specific characteristics associated with this non-adherence:

• Educational Attainment: Candidates who had completed some college education were more likely to be medication non-adherent (Odds Ratio [OR]: 1.73; 95% Confidence Interval [CI]: 1.06, 2.81). This finding, while initially counterintuitive, has been observed in other studies and suggests potential complexities related to health literacy, self-advocacy, or competing life demands among more educated individuals.
• Emotional Well-being: Lower positive affect scores (OR: 0.95; CI: 0.92, 0.99) and a lower positivity ratio (the balance of positive to negative emotions) were significantly associated with medication non-adherence. Conversely, a higher positivity ratio predicted adherence. This highlights the critical role of emotional resilience and positive outlook in maintaining adherence to complex medical regimens.
• Illness Uncertainty: Higher levels of illness uncertainty, particularly related to the complexity of the illness, were linked to increased odds of medication non-adherence (Total MUIS score OR: 1.02; CI: 1.01, 1.04; Complexity sub-score OR: 1.10; CI: 1.03, 1.17). Patients experiencing greater ambiguity or unpredictability regarding their condition may struggle more with managing their treatment plans.
• Anxiety: While positive screens on the GAD-2 were not significantly associated with MNA when treated as binary variables, continuous GAD-2 scores showed an increased odds of non-adherence (OR: 1.23; CI: 1.04, 1.48). This suggests that even sub-clinical levels of anxiety may influence a patient’s ability to adhere to medication protocols.

Interestingly, demographic factors such as age, sex, marital status, race, and body mass index (BMI) did not show a significant association with medication adherence. Furthermore, commonly used pre-transplant psychosocial assessment tools like the Psychosocial Assessment of Candidate for Transplantation (PACT) and the Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) did not correlate with adherence rates in this study.

Impact on Transplant Outcomes

The study also examined the relationship between pre-transplant medication non-adherence and key waitlist outcomes. Medication non-adherent candidates were found to be less likely to receive an organ transplant during the study period (OR: 0.61; CI: 0.38, 0.99) compared to their adherent counterparts. This finding underscores how transplant teams perceive medication adherence as a critical factor in patient selection and readiness for transplantation. While no significant differences were observed in waitlist removal, overall death, or 1-year post-transplant mortality, the reduced likelihood of receiving a transplant for non-adherent individuals is a significant implication.

Analysis and Implications

The high prevalence of medication non-adherence among thoracic transplant candidates (over 60%) is a concerning finding that demands attention. The identification of specific psychosocial and emotional factors as predictors of non-adherence offers a promising avenue for targeted interventions. The link between higher education and non-adherence, though paradoxical, suggests a need for further research into the underlying mechanisms. Hypotheses include increased questioning of medical advice, potential over-reliance on self-researched information that may contradict clinical recommendations, or simply increased time constraints and competing demands that can lead to unintentional non-adherence.

The study’s strength lies in its multi-center design, large cohort size, and comprehensive use of validated assessment tools, providing a robust picture of pre-transplant adherence challenges. The excellent response rate of 91.1% further enhances the reliability of the findings. The utilization of the SMAQ, a global measure of adherence, is a key differentiator, allowing for an assessment of adherence across diverse pre-transplant medication regimens.

Limitations and Future Directions

Despite its strengths, the study acknowledges certain limitations. The limited number of post-transplant deaths during the study period may have resulted in insufficient statistical power to demonstrate a definitive association with post-transplant mortality. The use of SMAQ, while practical, may limit direct comparisons with studies employing transplant-specific adherence instruments. The analyses were univariate, and future research with larger sample sizes should employ multivariable modeling to account for potential confounding factors. Additionally, the predominantly white and married demographic of the cohort may limit the generalizability of findings to more diverse populations. The study also notes that the sickest candidates, who might have less capacity or time to complete surveys, may have been underrepresented.

The implications of these findings are substantial. Transplant teams can leverage this information to proactively screen candidates exhibiting characteristics associated with higher risk of non-adherence, such as lower positive affect or greater illness uncertainty. Implementing individualized behavioral or psychosocial interventions during the transplant evaluation process could significantly enhance adherence and optimize transplant readiness. The study’s findings align with existing evidence that pre-transplant adherence behaviors strongly predict post-transplant adherence, suggesting that early intervention can have a lasting positive impact.

Conclusion

This multi-center study provides critical insights into the prevalence and predictors of medication non-adherence among thoracic transplant candidates. By identifying key psychosocial factors, the research offers a roadmap for transplant teams to develop targeted strategies aimed at improving medication adherence. Proactive screening and the implementation of tailored interventions during the pre-transplant evaluation phase hold the potential to not only optimize transplant readiness but also to significantly improve long-term outcomes for these vulnerable patients. Further research is warranted to validate these findings and to rigorously evaluate the effectiveness of interventions designed to modify these identified psychosocial risk factors. The ultimate goal is to ensure that patients embarking on the transplant journey are equipped with the best possible foundation for sustained health and recovery.